Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

Aberrant P-cadherin expression is a feature of clonal expansion in the gastrointestinal tract associated with repair and neoplasia.

Sanders DS, Perry I, Hardy R, Jankowski J.

J Pathol. 2000 Apr;190(5):526-30. Review.

PMID:
10727977
2.

Alterations of E-cadherin, alpha-catenin and beta-catenin expression in neuroendocrine tumors of the gastrointestinal tract.

Li CC, Xu B, Hirokawa M, Qian Z, Yoshimoto K, Horiguchi H, Tashiro T, Sano T.

Virchows Arch. 2002 Feb;440(2):145-54.

PMID:
11964044
3.

Alterations in classical cadherins associated with progression in ulcerative and Crohn's colitis.

Jankowski JA, Bedford FK, Boulton RA, Cruickshank N, Hall C, Elder J, Allan R, Forbes A, Kim YS, Wright NA, Sanders DS.

Lab Invest. 1998 Sep;78(9):1155-67.

PMID:
9759659
4.

Loss of Smad4 correlates with loss of the invasion suppressor E-cadherin in advanced colorectal carcinomas.

Reinacher-Schick A, Baldus SE, Romdhana B, Landsberg S, Zapatka M, Mönig SP, Hölscher AH, Dienes HP, Schmiegel W, Schwarte-Waldhoff I.

J Pathol. 2004 Apr;202(4):412-20.

PMID:
15095268
5.

Expression of E-cadherin, P-cadherin and N-cadherin in oral squamous cell carcinoma: correlation with the clinicopathologic features and patient outcome.

Pyo SW, Hashimoto M, Kim YS, Kim CH, Lee SH, Johnson KR, Wheelock MJ, Park JU.

J Craniomaxillofac Surg. 2007 Jan;35(1):1-9. Epub 2007 Feb 12.

PMID:
17296306
6.

Expression of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex correlates with the macroscopic appearance of early gastric cancer.

Ohene-Abuakwa Y, Noda M, Perenyi M, Kobayashi N, Kashima K, Hattori T, Pignatelli M.

J Pathol. 2000 Dec;192(4):433-9.

PMID:
11113859
7.

E-cadherin and alpha-, beta-, and gamma-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions.

Davidson B, Berner A, Nesland JM, Risberg B, Berner HS, Tropè CG, Kristensen GB, Bryne M, Ann Florenes V.

J Pathol. 2000 Dec;192(4):460-9.

PMID:
11113863
8.

Repressed E-cadherin expression in the lower crypt of human small intestine: a cell marker of functional relevance.

Escaffit F, Perreault N, Jean D, Francoeur C, Herring E, Rancourt C, Rivard N, Vachon PH, Paré F, Boucher MP, Auclair J, Beaulieu JF.

Exp Cell Res. 2005 Jan 15;302(2):206-20.

PMID:
15561102
9.

Down-regulation of E-cadherin is closely associated with progression of cervical intraepithelial neoplasia (CIN), but not with high-risk human papillomavirus (HPV) or disease outcome in cervical cancer.

Branca M, Giorgi C, Ciotti M, Santini D, Di Bonito L, Costa S, Benedetto A, Bonifacio D, Di Bonito P, Paba P, Accardi L, Mariani L, Syrjänen S, Favalli C, Syrjänen K; HPV-PathogenISS Study Group.

Eur J Gynaecol Oncol. 2006;27(3):215-23.

PMID:
16800245
10.

Gains and losses of adhesion molecules (CD44, E-cadherin, and beta-catenin) during oral carcinogenesis and tumour progression.

Bánkfalvi A, Krassort M, Buchwalow IB, Végh A, Felszeghy E, Piffkó J.

J Pathol. 2002 Nov;198(3):343-51.

PMID:
12375267
11.

Transient P-cadherin expression in radiation proctitis; a model of mucosal injury and repair.

Hardy RG, Brown RM, Miller SJ, Tselepis C, Morton DG, Jankowski JA, Sanders DS.

J Pathol. 2002 Jun;197(2):194-200.

PMID:
12015743
12.

Expression of classic cadherins type I in urothelial neoplastic progression.

Rieger-Christ KM, Cain JW, Braasch JW, Dugan JM, Silverman ML, Bouyounes B, Libertino JA, Summerhayes IC.

Hum Pathol. 2001 Jan;32(1):18-23.

PMID:
11172290
13.

Aberrant expression of E-cadherin and beta-catenin in human prostate cancer.

Jaggi M, Johansson SL, Baker JJ, Smith LM, Galich A, Balaji KC.

Urol Oncol. 2005 Nov-Dec;23(6):402-6.

PMID:
16301117
14.

Down regulation of adhesion protein E-cadherin in Epstein-Barr virus infected nasopharyngeal carcinomas.

Krishna SM, Kattoor J, Balaram P.

Cancer Biomark. 2005;1(6):271-7.

PMID:
17192051
15.

Transcriptional regulation of cadherins during development and carcinogenesis.

Peinado H, Portillo F, Cano A.

Int J Dev Biol. 2004;48(5-6):365-75. Review.

16.

Expression of CD44v6 but not E-cadherin or beta-catenin influences prognosis in primary pulmonary adenocarcinoma.

Ramasami S, Kerr KM, Chapman AD, King G, Cockburn JS, Jeffrey RR.

J Pathol. 2000 Dec;192(4):427-32.

PMID:
11113858
17.

Altered distribution of beta-catenin, and its binding proteins E-cadherin and APC, in ulcerative colitis-related colorectal cancers.

Aust DE, Terdiman JP, Willenbucher RF, Chew K, Ferrell L, Florendo C, Molinaro-Clark A, Baretton GB, Löhrs U, Waldman FM.

Mod Pathol. 2001 Jan;14(1):29-39.

18.

Immunohistochemical analysis of candidate gene product expression in the duodenal epithelium of children with coeliac sprue.

Barshack I, Goldberg I, Chowers Y, Weiss B, Horowitz A, Kopolovic J.

J Clin Pathol. 2001 Sep;54(9):684-8.

19.

Systematic analysis of E-, N- and P-cadherin expression in mouse eye development.

Xu L, Overbeek PA, Reneker LW.

Exp Eye Res. 2002 Jun;74(6):753-60.

PMID:
12126948
20.

[Cadherins in malignancies of the female genital tract].

Piura B, Rabinovich A, Aizenberg N, Wolfson M.

Harefuah. 2005 Apr;144(4):261-5, 303, 302. Review. Hebrew.

PMID:
15889610

Supplemental Content

Support Center